Work

Inebilizumab, a novel anti-CD19 antibody for treatment of IgG4-related disease: an overview from clinical trials

Year: 2026

Type: article

Source: Expert Opinion on Biological Therapy

DOI: 10.1080/14712598.2026.2634052

Author: Yoshiya Tanaka

Institution: University of Occupational and Environmental Health Japan

Language: English

Topic: IgG4-Related and Inflammatory Diseases

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7130655169

FWCI: 4.965

Cites: 37

Cited by: 1

Related to: